Revive Therapeutics (RVV.CN) traded flat 0 % during a 24 hours period ending at 01:08 AM Central Europe on Tuesday 27th. One Revive Therapeutics stock can currently be bought for about CAD 0.02 on popular exchanges. Current supply of Revive Therapeutics stocks is 435.7 mn. Revive Therapeutics has a current market capitalization of CAD 8.7 mn and approximately CAD 7.1 k worth of Revive Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Revive Therapeutics has traded -20 % down. Simple moving average of last 200 days is at CAD 0.03. The highest price of past 52 weeks was recorded at CAD 0.08 on 03/17/2026. 52 weeks low was at CAD 0 on 12/03/2025.
Here is how related stocks have performed in the past 24 hours:
Signature (SGU.V) traded flat 0 % and now trades at CAD 0.04. Current market capitalisation for Signature is CAD 10.4 mn.
Ironman (IMI.V) traded flat 0 % and now trades at CAD 0.06. Current market capitalisation for Ironman is CAD 10.4 mn.
Dinero Ventures (DNO.V) traded flat 0 % and now trades at CAD 0.3. Current market capitalisation for Dinero Ventures is CAD 10.3 mn.
Heritage Mining (HML.CN) traded flat 0 % and now trades at CAD 0.04. Current market capitalisation for Heritage Mining is CAD 10.3 mn.
Domestic Metals (DMCU.V) traded up 3.57 % and now trades at CAD 0.14. Current market capitalisation for Domestic Metals is CAD 10.4 mn.
About Revive Therapeutics
Revive Therapeutics Ltd. is a Canadian health care company that specializes in developing and commercializing cannabinoid-based products. The company has successfully completed Phase II-A clinical studies for their bucillamine called REV-002, which is being developed for the treatment of acute gout flares. You can find more information about this company and their offerings on their website, www.revivethera.com , and they are listed on the Canadian National Stock Exchange.
